These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 10197036
21. Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering. Lešnik U, Lukežič T, Podgoršek A, Horvat J, Polak T, Šala M, Jenko B, Harmrolfs K, Ocampo-Sosa A, Martínez-Martínez L, Herron PR, Fujs Š, Kosec G, Hunter IS, Müller R, Petković H. Angew Chem Int Ed Engl; 2015 Mar 23; 54(13):3937-40. PubMed ID: 25650563 [Abstract] [Full Text] [Related]
25. In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria. Wexler HM, Molitoris E, Finegold SM. Antimicrob Agents Chemother; 1994 Oct 23; 38(10):2513-5. PubMed ID: 7840601 [Abstract] [Full Text] [Related]
26. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria. Brown BA, Wallace RJ, Onyi G. Antimicrob Agents Chemother; 1996 Apr 23; 40(4):874-8. PubMed ID: 8849243 [Abstract] [Full Text] [Related]
28. Tigecycline: clinical evidence and formulary positioning. Nathwani D. Int J Antimicrob Agents; 2005 Mar 23; 25(3):185-92. PubMed ID: 15737510 [Abstract] [Full Text] [Related]
29. In vitro activities of two glycylcyclines. Wise R, Andrews JM. Antimicrob Agents Chemother; 1994 May 23; 38(5):1096-102. PubMed ID: 8067744 [Abstract] [Full Text] [Related]
30. 8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents. Clark RB, He M, Fyfe C, Lofland D, O'Brien WJ, Plamondon L, Sutcliffe JA, Xiao XY. J Med Chem; 2011 Mar 10; 54(5):1511-28. PubMed ID: 21302930 [Abstract] [Full Text] [Related]
32. Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines. Whittington WL, Roberts MC, Hale J, Holmes KK. Antimicrob Agents Chemother; 1995 Aug 10; 39(8):1864-5. PubMed ID: 7486935 [Abstract] [Full Text] [Related]
33. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter. Someya Y, Yamaguchi A, Sawai T. Antimicrob Agents Chemother; 1995 Jan 10; 39(1):247-9. PubMed ID: 7695316 [Abstract] [Full Text] [Related]
34. The emergence of clinical resistance to tigecycline. Sun Y, Cai Y, Liu X, Bai N, Liang B, Wang R. Int J Antimicrob Agents; 2013 Feb 10; 41(2):110-6. PubMed ID: 23127485 [Abstract] [Full Text] [Related]
35. In-vitro activity of two glycylcyclines against enterococci resistant to other agents. Fraise AP, Brenwald N, Andrews JM, Wise R. J Antimicrob Chemother; 1995 Jun 10; 35(6):877-81. PubMed ID: 7559199 [Abstract] [Full Text] [Related]
36. Tigecycline: a glycylcycline antimicrobial agent. Doan TL, Fung HB, Mehta D, Riska PF. Clin Ther; 2006 Aug 10; 28(8):1079-1106. PubMed ID: 16982286 [Abstract] [Full Text] [Related]
37. Synthesis and antibacterial activity of 9-substituted minocycline derivatives. Sum PE, Ross AT, Petersen PJ, Testa RT. Bioorg Med Chem Lett; 2006 Jan 15; 16(2):400-3. PubMed ID: 16246559 [Abstract] [Full Text] [Related]
38. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Diagn Microbiol Infect Dis; 2005 Jul 15; 52(3):195-201. PubMed ID: 16105564 [Abstract] [Full Text] [Related]